These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8823489)

  • 1. Inhibitory effect of a spicamycin derivative, KRN5500, on the growth of hepatic metastasis of human colon cancer-producing tissue polypeptide antigen.
    Kamishohara M; Kawai H; Sakai T; Uchida T; Tsuruo T; Otake N
    Cancer Chemother Pharmacol; 1996; 38(6):495-8. PubMed ID: 8823489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of a spicamycin derivative, KRN5500, and its active metabolite in tumor cells.
    Kamishohara M; Kawai H; Sakai T; Isoe T; Hasegawa K; Mochizuki J; Uchida T; Kataoka S; Yamaki H; Tsuruo T
    Oncol Res; 1994; 6(8):383-90. PubMed ID: 7894087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KRN5500, a spicamycin derivative, exerts anti-myeloma effects through impairing both myeloma cells and osteoclasts.
    Miki H; Ozaki S; Nakamura S; Oda A; Amou H; Ikegame A; Watanabe K; Hiasa M; Cui Q; Harada T; Fujii S; Nakano A; Kagawa K; Takeuchi K; Yata K; Sakai A; Abe M; Matsumoto T
    Br J Haematol; 2011 Nov; 155(3):328-39. PubMed ID: 21902681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative activity in vitro and in vivo of the spicamycin analogue KRN5500 with altered glycoprotein expression in vitro.
    Burger AM; Kaur G; Hollingshead M; Fischer RT; Nagashima K; Malspeis L; Duncan KL; Sausville EA
    Clin Cancer Res; 1997 Mar; 3(3):455-63. PubMed ID: 9815705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I clinical trial and pharmacokinetic study of the spicamycin analog KRN5500 administered as a 1-hour intravenous infusion for five consecutive days to patients with refractory solid tumors.
    Supko JG; Eder JP; Ryan DP; Seiden MV; Lynch TJ; Amrein PC; Kufe DW; Clark JW
    Clin Cancer Res; 2003 Nov; 9(14):5178-86. PubMed ID: 14613997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effect of FP3 in combination with cetuximab on patient-derived tumor tissue xenograft models of primary colon carcinoma and related lymphatic and hepatic metastases.
    Dong X; Jin K; Hu X; Du F; Lan H; Han N; Ma Z; Xie B; Cui B; Teng L; Cao F
    Int J Mol Med; 2012 Jul; 30(1):126-32. PubMed ID: 22505231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of somatostatin analogue RC-160 on the growth of hepatic metastases of colon cancer in rats: a study with magnetic resonance imaging.
    Qin Y; Van Cauteren M; Osteaux M; Schally AV; Willems G
    Cancer Res; 1992 Nov; 52(21):6025-30. PubMed ID: 1356623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro interactions of a new derivative of spicamycin, KRN5500, and other anticancer drugs using a three-dimensional model.
    Kanzawa F; Nishio K; Fukuoka K; Sunami T; Saijo N
    Cancer Chemother Pharmacol; 1999; 43(5):353-63. PubMed ID: 10100589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitory effect of lidamycin on growth of colon carcinoma 26 and hepatic metastasis in mice].
    Liu XJ; Dai Y; Shang Y; Li Y; Zhen YS
    Ai Zheng; 2005 Jun; 24(6):641-5. PubMed ID: 15946470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of combined radioimmunotherapy and anti-angiogenic therapy in a liver metastasis model of human colon cancer cells.
    Li XF; Kinuya S; Yokoyama K; Koshida K; Mori H; Shiba K; Watanabe N; Shuke N; Michigishi T; Tonami N
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1669-74. PubMed ID: 12458402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition of growth and metastases of human colon cancer xenograft in nude mice by angiogenesis inhibitor endostatin].
    Zhang GF; Wang YH; Zhang MA; Wang Q; Luo YB; Wang DS; Han CR
    Ai Zheng; 2002 Jan; 21(1):50-3. PubMed ID: 12500397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental cancer chemotherapy using a liver metastatic model of human colon cancer transplanted into the spleen of severe combined immunodeficient mice.
    Kuo TH; Kubota T; Nishibori H; Watanabe M; Furukawa T; Kase S; Tanino H; Saikawa Y; Teramoto T; Kitajima M
    J Surg Oncol; 1993 Feb; 52(2):92-6. PubMed ID: 8468978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitory effect of boanmycin on the growth of colon carcinoma 26 and hepatic metastasis in mice].
    Liu XJ; Li Y; Zhen YS
    Yao Xue Xue Bao; 2001 Jan; 36(1):14-8. PubMed ID: 12579853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TSU-68 (SU6668) inhibits local tumor growth and liver metastasis of human colon cancer xenografts via anti-angiogenesis.
    Yorozuya K; Kubota T; Watanabe M; Hasegawa H; Ozawa S; Kitajima M; Chikahisa LM; Yamada Y
    Oncol Rep; 2005 Sep; 14(3):677-82. PubMed ID: 16077974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of the side effects of an antitumor agent, KRN5500, by incorporation of the drug into polymeric micelles.
    Matsumura Y; Yokoyama M; Kataoka K; Okano T; Sakurai Y; Kawaguchi T; Kakizoe T
    Jpn J Cancer Res; 1999 Jan; 90(1):122-8. PubMed ID: 10076575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensive liver metastasis from human colon cancer in nude and scid mice after orthotopic onplantation of histologically-intact human colon carcinoma tissue.
    Fu X; Herrera H; Kubota T; Hoffman RM
    Anticancer Res; 1992; 12(5):1395-7. PubMed ID: 1444196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Spicamycin derivative].
    Mizumura Y
    Nihon Rinsho; 2006 Feb; 64(2):322-8. PubMed ID: 16454188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antitumor activity of T-506, a novel synthetic FUDR derivative, on murine colon cancer and its hepatic metastasis].
    Kuroki Y; Yamashita I; Okamoto M; Ochiai H; Kurokawa M; Tazawa K; Fujimaki M
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1297-302. PubMed ID: 1829881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model.
    Nishikawa M; Stapleton PP; Freeman TA; Gaughan JP; Matsuda T; Daly JM
    J Am Coll Surg; 2004 Sep; 199(3):428-35. PubMed ID: 15325613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibitory effects of Forskolin on hepatic metastasis from human colon cancer in nude mice].
    Yoshizawa J; Yoshida K; Fujikawa T; Tanabe A; Sakurai K
    Nihon Geka Gakkai Zasshi; 1995 Jan; 96(1):26-30. PubMed ID: 7898427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.